Pharmaceutical News

RSS

New study reveals key to more effective antihistamines

Even if two molecules have the exact same chemical formula and the same number and types of bonds, their three-dimensional arrangements can still be different.

1 Jul 2024

Radiometer celebrates 70 years in acute care diagnostics

In 1954, Radiometer launched the world’s first commercially available blood gas analyzer. This event catapulted a small Danish company that produced devices for the radio industry into the foray of acute care diagnostics.

From Radiometer Medical 1 Jul 2024

Showcasing neuroprotective effects of citicoline at NUTRITION 2024

Kyowa Hakko Bio Co., Ltd. and Kirin Holdings Company, Limited are thrilled to announce their sponsored satellite program at the American Society for Nutrition's (ASN) Annual Conference, NUTRITION 2024.

28 Jun 2024

Google searches reveal growing interest in microdosing amid changing drug policies

Loosening local, state and federal regulations on cannabis and psychedelics has increased Americans' interest in microdosing, according to a study from researchers at the University of California San Diego.

28 Jun 2024

Psilocybin mushrooms in America: Usage trends and policy implications

Psilocybin mushrooms are the psychedelic substance most often used in the U.S., with its popularity outpacing other psychedelic drugs such as MDMA (known as ecstasy), according to a new RAND report.

27 Jun 2024

Study reveals exercise and GLP-1 RA combination preserves bone health during weight loss

Combining exercise with GLP-1 RA liraglutide results in significant weight loss while preserving bone health in adults with obesity.

27 Jun 2024

Technological solutions for improving medication adherence

Medication non-adherence is a major societal problem with serious clinical and economic consequences, associated with 200,000 deaths and 125 billion euros of costs annually in Europe.

26 Jun 2024

Atogepant may decrease the risk of developing rebound headache in people with migraine

A drug used to prevent migraine may also be effective in people with migraine who experience rebound headaches, according to a new study published in the June 26, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

26 Jun 2024

NCCN survey reveals ongoing shortages in crucial cancer medications

The National Comprehensive Cancer Network (NCCN) - a nonprofit alliance of leading cancer centers - is publishing new results for its latest survey on cancer drug shortages in the United States.

26 Jun 2024

Differences in effectiveness among antihyperglycemic drugs on dementia risk identified in recent study

Researchers compare the effectiveness of anti-diabetes medications in reducing the risk of dementia in older diabetics.

26 Jun 2024

Semaglutide reduces heart risks in overweight and obese individuals without diabetes

The SELECT trial found that semaglutide significantly reduces cardiovascular events in individuals with overweight or obesity and preexisting cardiovascular disease, regardless of baseline HbA1c or changes in HbA1c levels.

26 Jun 2024

Extended-release ketamine tablets offer new hope for treatment-resistant depression

The BEDROC trial found that extended-release ketamine tablets (R-107) significantly improve depressive symptoms in treatment-resistant depression patients, with the 180 mg dose showing the most efficacy. The treatment was well-tolerated with minimal side effects.

26 Jun 2024

Semaglutide proves a game-changer for kidney and heart health in diabetes patients

The FLOW trial demonstrated that semaglutide significantly improves kidney and cardiovascular outcomes in people with chronic kidney disease and type 2 diabetes, irrespective of SGLT2 inhibitor use.

25 Jun 2024

3D drug printers could help personalize medications in the future

Chocolate-flavored pills for children who hate taking medicine.

25 Jun 2024

New MDMA variants could be promising alternatives for safe psychotherapeutic applications

The use of the active ingredient 3,4-methylenedioxy-N-methylamphetamine (MDMA), commonly known as "ecstasy", to support psychotherapy for mental illnesses such as post-traumatic stress disorder is being discussed worldwide.

25 Jun 2024

FDA expands orphan drug designation for Roswell Park's brain cancer immunotherapy

The U.S. Food and Drug Administration (FDA) has expanded orphan drug designation for SurVaxM, a brain cancer immunotherapy born in the labs of Roswell Park Comprehensive Cancer Center.

25 Jun 2024

Study reveals high rates of aspirin use for CVD prevention among older adults

A survey representing about 150 million adults annually suggests that aspirin use for primary prevention of cardiovascular disease (CVD) remains prevalent among older adults, contrary to recommendations from the American College of Cardiology and the American Heart Association.

24 Jun 2024

Breakthrough in hemophilia A treatment: Sobi's ALTUVOCT receives EU marketing authorization

Sobi® today announced the European Commission has granted Marketing Authorization for ALTUVOCT™ (efanesoctocog alfa), for the treatment and prevention of bleeds and perioperative prophylaxis in hemophilia A. ALTUVOCT is a high-sustained factor VIII replacement therapy for all ages and any disease severity.

22 Jun 2024

Semaglutide weight loss results linked to diabetes severity

Researchers investigate the weight loss outcomes of semaglutide treatment in obese patients with type 2 diabetes.

21 Jun 2024

GLP-1 agonists linked to reduced dementia risk in type 2 diabetes patients

People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from Karolinska Institutet in Sweden published in the journal eClinicalMedicine.

20 Jun 2024

Previous
1
...
48
49
50
51
52
53
54
...
1467
Next

Pharmaceutical News

New study reveals key to more effective antihistamines

Radiometer celebrates 70 years in acute care diagnostics

Showcasing neuroprotective effects of citicoline at NUTRITION 2024

Google searches reveal growing interest in microdosing amid changing drug policies

Psilocybin mushrooms in America: Usage trends and policy implications

Study reveals exercise and GLP-1 RA combination preserves bone health during weight loss

Technological solutions for improving medication adherence

Atogepant may decrease the risk of developing rebound headache in people with migraine

NCCN survey reveals ongoing shortages in crucial cancer medications

Differences in effectiveness among antihyperglycemic drugs on dementia risk identified in recent study

Semaglutide reduces heart risks in overweight and obese individuals without diabetes

Extended-release ketamine tablets offer new hope for treatment-resistant depression

Semaglutide proves a game-changer for kidney and heart health in diabetes patients

3D drug printers could help personalize medications in the future

New MDMA variants could be promising alternatives for safe psychotherapeutic applications

FDA expands orphan drug designation for Roswell Park's brain cancer immunotherapy

Study reveals high rates of aspirin use for CVD prevention among older adults

Breakthrough in hemophilia A treatment: Sobi's ALTUVOCT receives EU marketing authorization

Semaglutide weight loss results linked to diabetes severity

GLP-1 agonists linked to reduced dementia risk in type 2 diabetes patients

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News